TAGLN2
Transgelin-2 · P37802 · TAGLN2 on Sugi Atlas →
0 patent compounds predicted against TAGLN2, 0 high-confidence (nearest known ligand ≥ 0.5)
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to TAGLN2 by text similarity (a relevance ranking, not an exhaustive list)
Related proteins — ESM-2 sequence neighbours (a TAGLN2 binder may also engage these)
| Protein | Name | Similarity | |
|---|---|---|---|
| Q5E9F5 | — | 1.000 | Q5E9F5 → |
| Q5XFX0 | — | 1.000 | Q5XFX0 → |
| Q9R1Q8 | — | 1.000 | Q9R1Q8 → |
| Q9UI15 | — | 1.000 | Q9UI15 → |
| Q5R6R2 | — | 1.000 | Q5R6R2 → |
| Q4R5J4 | — | 1.000 | Q4R5J4 → |
| P37805 | — | 1.000 | P37805 → |
| Q3ZBY2 | — | 1.000 | Q3ZBY2 → |
| Q9WVA4 | — | 1.000 | Q9WVA4 → |
| P37804 | — | 1.000 | P37804 → |
| P31232 | — | 1.000 | P31232 → |
| Q01995 | — | 1.000 | Q01995 → |
| Q9TS87 | — | 1.000 | Q9TS87 → |
| P37803 | — | 0.995 | P37803 → |
| P19966 | — | 0.995 | P19966 → |
| O14185 | — | 0.995 | O14185 → |
| P51911 | — | 0.994 | P51911 → |
| Q08092 | — | 0.994 | Q08092 → |
| Q08094 | — | 0.992 | Q08094 → |
| Q7YRL2 | — | 0.991 | Q7YRL2 → |
| Q2HJ38 | — | 0.991 | Q2HJ38 → |
| Q08873 | — | 0.991 | Q08873 → |
| P26932 | — | 0.990 | P26932 → |
| Q08091 | — | 0.988 | Q08091 → |
| Q08290 | — | 0.988 | Q08290 → |
| Q9GK38 | — | 0.987 | Q9GK38 → |
| Q99K51 | — | 0.987 | Q99K51 → |
| Q3SYU6 | — | 0.986 | Q3SYU6 → |
| Q9XUB9 | — | 0.986 | Q9XUB9 → |
| Q5RFN6 | — | 0.986 | Q5RFN6 → |